mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0004 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0004 |
mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.0004 |
mRNA |
ceranib-2 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0005 |
mRNA |
regorafenib |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0005 |
mRNA |
MLN4924 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0005 |
mRNA |
CP466722 |
GDSC1000 |
pan-cancer |
AAC |
0.1 |
0.0005 |
mRNA |
Sunitinib |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0006 |
mRNA |
Nilotinib |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.0007 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.0008 |